PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
Raina, Kanak, Lu, Jing, Qian, Yimin, Altieri, Martha, Gordon, Deborah, Rossi, Ann Marie K., Wang, Jing, Chen, Xin, Dong, Hanqing, Siu, Kam, Winkler, James D., Crew, Andrew P., Crews, Craig M., Coleman, Kevin G.
Published in Proceedings of the National Academy of Sciences - PNAS (28.06.2016)
Published in Proceedings of the National Academy of Sciences - PNAS (28.06.2016)
Get full text
Journal Article
Identification and Characterization of Von Hippel-Lindau-Recruiting Proteolysis Targeting Chimeras (PROTACs) of TANK-Binding Kinase 1
Crew, Andrew P, Raina, Kanak, Dong, Hanqing, Qian, Yimin, Wang, Jing, Vigil, Dominico, Serebrenik, Yevgeniy V, Hamman, Brian D, Morgan, Alicia, Ferraro, Caterina, Siu, Kam, Neklesa, Taavi K, Winkler, James D, Coleman, Kevin G, Crews, Craig M
Published in Journal of medicinal chemistry (25.01.2018)
Published in Journal of medicinal chemistry (25.01.2018)
Get full text
Journal Article
Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance
Salami, Jemilat, Alabi, Shanique, Willard, Ryan R., Vitale, Nick J., Wang, Jing, Dong, Hanqing, Jin, Meizhong, McDonnell, Donald P., Crew, Andrew P., Neklesa, Taavi K., Crews, Craig M.
Published in Communications biology (02.08.2018)
Published in Communications biology (02.08.2018)
Get full text
Journal Article
Preclinical characterization of OSI-027, a potent and selective inhibitor of mTORC1 and mTORC2: distinct from rapamycin
Bhagwat, Shripad V, Gokhale, Prafulla C, Crew, Andrew P, Cooke, Andy, Yao, Yan, Mantis, Christine, Kahler, Jennifer, Workman, Jennifer, Bittner, Mark, Dudkin, Lorina, Epstein, David M, Gibson, Neil W, Wild, Robert, Arnold, Lee D, Houghton, Peter J, Pachter, Jonathan A
Published in Molecular cancer therapeutics (01.08.2011)
Published in Molecular cancer therapeutics (01.08.2011)
Get full text
Journal Article
The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study
Burslem, George M., Smith, Blake E., Lai, Ashton C., Jaime-Figueroa, Saul, McQuaid, Daniel C., Bondeson, Daniel P., Toure, Momar, Dong, Hanqing, Qian, Yimin, Wang, Jing, Crew, Andrew P., Hines, John, Crews, Craig M.
Published in Cell chemical biology (18.01.2018)
Published in Cell chemical biology (18.01.2018)
Get full text
Journal Article
Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4
Lu, Jing, Qian, Yimin, Altieri, Martha, Dong, Hanqing, Wang, Jing, Raina, Kanak, Hines, John, Winkler, James D., Crew, Andrew P., Coleman, Kevin, Crews, Craig M.
Published in Chemistry & biology (18.06.2015)
Published in Chemistry & biology (18.06.2015)
Get full text
Journal Article
OSI-930 : A novel selective inhibitor of kit and kinase insert domain receptor tyrosine kinases with antitumor activity in mouse xenograft models
GARTON, Andrew J, CREW, Andrew P. A, BITTNER, Mark A, KEILY, John F, BRINER, Paul, HIDDEN, Chris, SREBERNAK, Mary C, PIRRIT, Carrie, O'CONNOR, Matthew, ANNA CHAN, VULEVIC, Bojana, HENNINGER, Dwight, FRANKLIN, Maryland, HART, Karen, SENNELLO, Regina, LI, An-Hu, TAO ZHANG, RICHARDSON, Frank, EMERSON, David L, CASTELHANO, Arlindo L, ARNOLD, Lee D, GIBSON, Neil W, COOKE, Andrew R, WYNNE, Graham M, CASTALDO, Linda, KAHLER, Jennifer, WINSKI, Shannon L, FRANKS, April, BROWN, Eric N
Published in Cancer research (Chicago, Ill.) (15.01.2006)
Published in Cancer research (Chicago, Ill.) (15.01.2006)
Get full text
Journal Article
Discovery of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1: Optimization of kinase selectivity and pharmacokinetics
Hornberger, Keith R., Chen, Xin, Crew, Andrew P., Kleinberg, Andrew, Ma, Lifu, Mulvihill, Mark J., Wang, Jing, Wilde, Victoria L., Albertella, Mark, Bittner, Mark, Cooke, Andrew, Kadhim, Salam, Kahler, Jennifer, Maresca, Paul, May, Earl, Meyn, Peter, Romashko, Darlene, Tokar, Brianna, Turton, Roy
Published in Bioorganic & medicinal chemistry letters (15.08.2013)
Published in Bioorganic & medicinal chemistry letters (15.08.2013)
Get full text
Journal Article
Palladium-Catalyzed Direct Heck Arylation of Dual π-Deficient/π-Excessive Heteroaromatics. Synthesis of C-5 Arylated Imidazo[1,5-a]pyrazines
Wang, Jian-Xin, McCubbin, J. Adam, Jin, Meizhong, Laufer, Radoslaw S, Mao, Yunyu, Crew, Andrew P, Mulvihill, Mark J, Snieckus, Victor
Published in Organic letters (17.07.2008)
Published in Organic letters (17.07.2008)
Get full text
Journal Article
A highly effective one-pot synthesis of quinolines from o-nitroarylcarbaldehydes
Li, An-Hu, Ahmed, Eilaf, Chen, Xin, Cox, Matthew, Crew, Andrew P., Dong, Han-Qing, Jin, Meizhong, Ma, Lifu, Panicker, Bijoy, Siu, Kam W., Steinig, Arno G., Stolz, Kathryn M., Tavares, Paula A. R., Volk, Brian, Weng, Qinghua, Werner, Doug, Mulvihill, Mark J.
Published in Organic & biomolecular chemistry (01.01.2007)
Published in Organic & biomolecular chemistry (01.01.2007)
Get more information
Journal Article
The Crystal Structure of a Constitutively Active Mutant RON Kinase Suggests an Intramolecular Autophosphorylation Hypothesis
Wang, Jing, Steinbacher, Stefan, Augustin, Martin, Schreiner, Patrick, Epstein, David, Mulvihill, Mark J, Crew, Andrew P
Published in Biochemistry (Easton) (21.09.2010)
Published in Biochemistry (Easton) (21.09.2010)
Get full text
Journal Article
Discovery of potent, selective and orally bioavailable imidazo[1,5-a]pyrazine derived ACK1 inhibitors
Jin, Meizhong, Wang, Jing, Kleinberg, Andrew, Kadalbajoo, Mridula, Siu, Kam W., Cooke, Andrew, Bittner, Mark A., Yao, Yan, Thelemann, April, Ji, Qunsheng, Bhagwat, Shripad, Mulvihill, Kristen M., Rechka, Josef A., Pachter, Jonathan A., Crew, Andrew P., Epstein, David, Mulvihill, Mark J.
Published in Bioorganic & medicinal chemistry letters (15.02.2013)
Published in Bioorganic & medicinal chemistry letters (15.02.2013)
Get full text
Journal Article
Discovery and optimization of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1
Hornberger, Keith R., Berger, Dan M., Crew, Andrew P., Dong, Hanqing, Kleinberg, Andrew, Li, An-Hu, Medeiros, Matthew R., Mulvihill, Mark J., Siu, Kam, Tarrant, James, Wang, Jing, Weng, Felix, Wilde, Victoria L., Albertella, Mark, Bittner, Mark, Cooke, Andrew, Gray, Michael J., Maresca, Paul, May, Earl, Meyn, Peter, Peick, William, Romashko, Darlene, Tanowitz, Michael, Tokar, Brianna
Published in Bioorganic & medicinal chemistry letters (15.08.2013)
Published in Bioorganic & medicinal chemistry letters (15.08.2013)
Get full text
Journal Article
One-Pot Friedlander Quinoline Synthesis: Scope and Limitations
Li, An-Hu, Beard, David J., Coate, Heather, Honda, Ayako, Kadalbajoo, Mridula, Kleinberg, Andrew, Laufer, Radoslaw, Mulvihill, Kristen M., Nigro, Anthony, Rastogi, Pawan, Sherman, Dan, Siu, Kam W., Steinig, Arno G., Wang, Ti, Werner, Doug, Crew, Andrew P., Mulvihill, Mark J.
Published in Synthesis (Stuttgart) (01.05.2010)
Published in Synthesis (Stuttgart) (01.05.2010)
Get more information
Journal Article
Novel inhibitors of mTORC1 and mTORC2
Bhagwat, Shripad V, Crew, Andrew P
Published in Current opinion in investigational drugs (London, England : 2000) (01.06.2010)
Get more information
Published in Current opinion in investigational drugs (London, England : 2000) (01.06.2010)
Journal Article
Imidazo[1,5- a]pyrazines: Orally efficacious inhibitors of mTORC1 and mTORC2
Crew, Andrew P., Bhagwat, Shripad V., Dong, Hanqing, Bittner, Mark A., Chan, Anna, Chen, Xin, Coate, Heather, Cooke, Andrew, Gokhale, Prafulla C., Honda, Ayako, Jin, Meizhong, Kahler, Jennifer, Mantis, Christine, Mulvihill, Mark J., Tavares-Greco, Paula A., Volk, Brian, Wang, Jing, Werner, Douglas S., Arnold, Lee D., Pachter, Jonathan A., Wild, Robert, Gibson, Neil W.
Published in Bioorganic & medicinal chemistry letters (01.04.2011)
Published in Bioorganic & medicinal chemistry letters (01.04.2011)
Get full text
Journal Article
Azafulvenium methides: new extended dipolar systems
Sutcliffe, OB, Storr, RC, Gilchrist, TL, Rafferty, P, Crew, APA
Published in Chemical communications (Cambridge, England) (01.01.2000)
Published in Chemical communications (Cambridge, England) (01.01.2000)
Get full text
Journal Article
Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells
Saenz, D T, Fiskus, W, Qian, Y, Manshouri, T, Rajapakshe, K, Raina, K, Coleman, K G, Crew, A P, Shen, A, Mill, C P, Sun, B, Qiu, P, Kadia, T M, Pemmaraju, N, DiNardo, C, Kim, M-S, Nowak, A J, Coarfa, C, Crews, C M, Verstovsek, S, Bhalla, K N
Published in Leukemia (01.09.2017)
Published in Leukemia (01.09.2017)
Get full text
Journal Article
BRM BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE
WANG JING, STABEN LEANNA, DRAGOVICH PETER, CHEN HUIFEN, BERLIN MICHAEL, CREW ANDREW P
Year of Publication 28.08.2024
Get full text
Year of Publication 28.08.2024
Patent